October 22, 2013 | Israeli biomed company Neuroderm, which is developing a transdermal drug delivery system, is in the process of raising $5 million. “Globes” reports that the funds are being raised from current investors and new foreign investors.
The proceeds will be used to accelerate clinical trials and for a review of a possible IPO on Nasdaq in 2014.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023

Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023

Israel, UK Ink Deal For Greater Innovation Collaboration
September 21, 2023

ALS Drug Receives Patent In Israel, Europe, Japan
September 20, 2023
Facebook comments